At the end of the latest market close, Capricor Therapeutics Inc. (CAPR) was valued at $7.54. In that particular session, Stock kicked-off at the price of $8.79 while reaching the peak value of $9.56 and lowest value recorded on the day was $7.05. The stock current value is $8.12.
Recently in News on July 30, 2020, Capricor Therapeutics to Present Second Quarter 2020 Financial Results and Recent Corporate Update on August 6. Company to Host Conference Call and Webcast, August 6, 2020, at 4:30 p.m. ET. You can read further details here
Capricor Therapeutics Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $12.32 on 07/28/20, with the lowest value was $0.88 for the same time period, recorded on 03/12/20.
Capricor Therapeutics Inc. (CAPR) full year performance was 71.36%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Capricor Therapeutics Inc. shares are logging -34.09% during the 52-week period from high price, and 822.73% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.88 and $12.32.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 2299819 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Capricor Therapeutics Inc. (CAPR) recorded performance in the market was 489.06%, having the revenues showcasing 7.71% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 83.24M, as it employees total of 16 workers.
The Analysts eye on Capricor Therapeutics Inc. (CAPR)
During the last month, 0 analysts gave the Capricor Therapeutics Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 4.25, with a change in the price was noted +7.24. In a similar fashion, Capricor Therapeutics Inc. posted a movement of +769.99% for the period of last 100 days, recording 5,013,331 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for CAPR is recording 0.35 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.35.
Technical rundown of Capricor Therapeutics Inc. (CAPR)
Raw Stochastic average of Capricor Therapeutics Inc. in the period of last 50 days is set at 51.27%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 51.27%. In the last 20 days, the company’s Stochastic %K was 53.05% and its Stochastic %D was recorded 62.72%.
Considering, the past performance of Capricor Therapeutics Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 489.06%. Additionally, trading for the stock in the period of the last six months notably improved by 389.61%, alongside a boost of 71.36% for the period of the last 12 months. The shares increased approximately by 26.30% in the 7-day charts and went down by 63.91% in the period of the last 30 days. Common stock shares were driven by 7.71% during last recorded quarter.